ArticleBrain sciences2026

Targeting Hypoglossal Neurobiology in the Treatment of Obstructive Sleep Apnea: The Emergence of Aroxybutynin-Atomoxetine (AD109).

Stanley Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.